Panacos Pharmaceuticals, Inc.
PANC
Rank in Stocks
#34626
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm... Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$5.36K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Panacos Pharmaceuticals, Inc. (PANC)
Category
Healthcare
Operating Margin for Panacos Pharmaceuticals, Inc. (PANC)
Operating Margin as of November 2026 TTM: 21,678.89%
According to Panacos Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is 21,678.89%. At the end of 2007 the company had an operating margin of 21,678.89%.
Operating Margin history for Panacos Pharmaceuticals, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 21,678.89% | 0.00% |
| 2007 | 21,678.89% | 47.66% |
| 2006 | 14,681.34% | 156.75% |
| 2005 | 5,718.21% | 538.76% |
| 2004 | 895.21% | 122.82% |
| 2003 | 401.76% | -16.96% |
| 2002 | 483.80% | 676.57% |
| 2001 | 62.30% | 66.36% |
| 2000 | 37.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -100.01% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Panacos Pharmaceuticals, Inc.'s operating margin
What is Panacos Pharmaceuticals, Inc.'s operating margin?
Panacos Pharmaceuticals, Inc.'s operating margin is 21,678.89%, as of Nov 2026.
What was Panacos Pharmaceuticals, Inc.'s operating margin in 2007?
In 2007, Panacos Pharmaceuticals, Inc.'s operating margin was 21,678.89%, compared with 14,681.34% in 2006.
How has Panacos Pharmaceuticals, Inc.'s operating margin changed since 2002?
From 2002 to 2007, Panacos Pharmaceuticals, Inc.'s operating margin was highest in 2007 (21,678.89%) and lowest in 2003 (401.76%).
How does Panacos Pharmaceuticals, Inc.'s operating margin compare with similar companies?
Panacos Pharmaceuticals, Inc.'s operating margin (21,678.89%) is higher than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.